JCM | Free Full-Text | The Management of Postoperative Recurrence in Crohn’s Disease
Systematic review and meta-analysis: real-world data rates of deep remission with anti-TNFα in inflammatory bowel disease | BMC Gastroenterology | Full Text
European Crohn´s and Colitis Organisation - ECCO - Diet in the Treatment Paradigm of Crohn's Disease: New Evidence, New Strategies
Probiotic supplementation induces remission and changes in the immunoglobulins and inflammatory response in active ulcerative colitis patients: A pilot, randomized, double-blind, placebo-controlled study - Clinical Nutrition ESPEN
![available as Supplementary data at ECCO-JCC online]. | Download Table](https://www.researchgate.net/publication/289686991/figure/tbl1/AS:667881423507459@1536246748177/available-as-Supplementary-data-at-ECCO-JCC-online.png "available as Supplementary data at ECCO-JCC online]. | Download Table")
available as Supplementary data at ECCO-JCC online]. | Download Table
De-escalation of immunomodulator and biological therapy in inflammatory bowel disease - The Lancet Gastroenterology & Hepatology
The long-term effect of biologics in patients with ulcerative colitis emerging from a large Japanese cohort | Scientific Reports
Evidence-based clinical practice guidelines for inflammatory bowel disease 2020 | Journal of Gastroenterology
Serum biomarkers confirming stable remission in inflammatory bowel disease | Scientific Reports
How Do We Treat Inflammatory Bowel Diseases to Aim For Endoscopic Remission? - ScienceDirect
Frontiers | Monitoring of patients with active inflammatory bowel disease
Efficacy - RINVOQ® (upadacitinib) for Ulcerative Colitis
Ulcerative Colitis (UC): Efficacy | STELARA® (ustekinumab) HCP
Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease - ScienceDirect
Alimentary Pharmacology & Therapeutics | Pharmacology Journal | Wiley Online Library
Alimentary Pharmacology & Therapeutics | Pharmacology Journal | Wiley Online Library
Histologic Remission: The Ultimate Therapeutic Goal in Ulcerative Colitis? - ScienceDirect
Full article: Long-term deep remission during maintenance therapy with biological agents in inflammatory bowel diseases
Efficacy - RINVOQ® (upadacitinib) for Ulcerative Colitis
Frontiers | Inflammatory Indexes for Assessing the Severity and Disease Progression of Ulcerative Colitis: A Single-Center Retrospective Study
European Crohn´s and Colitis Organisation - ECCO - P193 Validation of the two-item UC patient-reported outcome (PRO2) against the simple clinical colitis activity index (SCCAI), measures of biochemical disease activity and quality
IBD treatment plan 'needs to be a continuous conversation'
Exploring the concept of deep remission in Crohn's disease: correlation between transmural healing and biomarkers - Fabiana Castiglione, Nicola Imperatore, Anna Testa, Roberto de Sire, Olga Maria Nardone, Simona Ricciolino, Imma Di
Artificial Intelligence Enabled Histological Prediction of Remission or Activity and Clinical Outcomes in Ulcerative Colitis - Gastroenterology
